文献速递脑血管病

儿童急性缺血性卒中合并心脏异常时血管内取栓的功能结局与安全性

Functional Outcomes and Safety of Endovascular Thrombectomy in Pediatric Acute Ischemic Stroke With Cardiac Abnormalities.
PubMed 文献 · Neurology · 2026-07-21

本研究为Save ChildS Pro前瞻性多国队列的回顾性二次分析,纳入178例28天至18岁大血管闭塞性急性缺血性卒中患儿,其中56例(31.5%)存在心脏异常。结果显示血管内治疗与功能结局改善相关,且心脏异常状态未显著改变该关联或安全性。

要点

  • 儿童AIS合并心脏异常者接受EVT的比例更高(p=0.003)。
  • 心脏异常状态与90天不良功能结局无独立关联(OR 0.93,95%CI 0.36-2.52)。
  • EVT与心脏异常状态之间无显著交互作用,支持临床指征下考虑EVT。

核心结论

  • 在儿童AIS队列中,EVT与功能结局改善和神经恢复加速相关,心脏异常状态未改变该关联或安全性。

研究设计与样本

  • 回顾性二次分析,数据来自前瞻性多国队列注册研究Save ChildS Pro,纳入2018至2023年患者并随访90天。
  • 最终分析纳入178例28天至18岁、确诊大血管闭塞性AIS且90天PSOM评分可用的患儿。

主要发现

  • 56例(31.5%)存在心脏异常,心脏异常组接受EVT的比例显著高于无心脏异常组(p=0.003)。
  • 心脏异常状态与90天不良功能结局(PSOM评分>0.5)无独立关联(OR 0.93,95%CI 0.36-2.52)。
  • 未观察到EVT与心脏异常状态之间的显著交互作用;序贯mRS偏移分析和纵向pedNIHSS建模支持相似的恢复轨迹。
  • 两个亚组中不良事件发生率均未因EVT状态不同而存在差异。

关键数值与推荐

  • 主要结局为90天不良功能结局,定义为PSOM评分>0.5。
  • 心脏异常定义为超声心动图或病历记录的先天性或获得性心脏病。

临床怎么用

  • 对于合并心脏异常的儿童AIS患者,当临床有指征时,应考虑血管内治疗。

局限性

  • 本研究为回顾性二次分析,证据等级为IV级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Cardiac abnormalities are among the most common and complex risk factors of pediatric acute ischemic stroke (AIS). Although endovascular treatment (EVT) is increasingly used in children, uncertainty persists regarding its safety and effectiveness in patients with underlying cardiac disease, leading to therapeutic hesitation in this high-risk population. The aim of this study was to determine whether the association between EVT and functional outcomes after pediatric AIS differs according to cardiac abnormality status. METHODS: This study was a retrospective secondary analysis of a prospective, multinational cohort registry (Save ChildS Pro). The registry enrolled patients between 2018 and 2023, with 90-day follow-up. Participants included children aged 28 days to 18 years with confirmed AIS due to large vessel occlusion and available 90-day Pediatric Stroke Outcome Measure (PSOM) scores. Cardiac abnormalities were defined as congenital or acquired cardiac disease documented by echocardiography or medical records. The primary outcome was poor functional outcome at 90 days, defined as PSOM score >0.5. Secondary outcomes included ordinal 90-day modified Rankin Scale (mRS) scores and longitudinal neurologic recovery assessed using the Pediatric NIH Stroke Scale (pedNIHSS). Treatment-subgroup interaction was assessed using penalized logistic regression. RESULTS: Of 208 eligible patients, 178 were included in the final analysis after excluding those with missing outcome data [43% female; mean age: 11.5 years]. Among 178 children, 56 (31.5%) had cardiac abnormalities. EVT was more frequently performed in children with cardiac abnormalities than in those without (p = 0.003). Cardiac abnormality status was not independently associated with outcome (odds ratio, 0.93; 95% CI, 0.36-2.52), and no significant interaction between EVT and cardiac abnormality was observed. Ordinal mRS shift analysis and longitudinal pedNIHSS modeling supported similar recovery trajectories. Adverse event rates did not differ by EVT status in either subgroup. DISCUSSION: In this multinational pediatric AIS cohort, EVT was associated with improved functional outcomes and accelerated neurologic recovery, with no evidence that cardiac abnormality status modifies association of treatment with outcome or safety. These findings support consideration of EVT in children with cardiac abnormalities when clinically indicated. CLASSIFICATION OF EVIDENCE: This study provides class IV evidence that endovascular therapy in pediatric patients with AIS is associated with improved functional outcome irrespective of underlying cardiac abnormality status.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Dmytriw AA, Kiani I, Kooshki A, et al. Functional Outcomes and Safety of Endovascular Thrombectomy in Pediatric Acute Ischemic Stroke With Cardiac Abnormalities. Neurology. 2026. PMID: 42479995. doi:10.1212/WNL.0000000000218270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。